Skip to main content
SpringerLink
Log in

Modeling of Protein Misfolding in Disease

  • Protocol
Book cover Molecular Modeling of Proteins

Part of the book series: Methods Molecular Biology™ ((MIMB,volume 443))

Summary

A short review of the results of molecular modeling of prion disease is presented in this chapter. According to the “one-protein theory” proposed by Prusiner, prion proteins are misfolded naturally occurring proteins, which, on interaction with correctly folded proteins may induce misfolding and propagate the disease, resulting in insoluble amyloid aggregates in cells of affected specimens. Because of experimental difficulties in measurements of origin and growth of insoluble amyloid aggregations in cells, theoretical modeling is often the only one source of information regarding the molecular mechanism of the disease. Replica exchange Monte Carlo simulations presented in this chapter indicate that proteins in the native state, N, on interaction with an energetically higher structure, R, can change their conformation into R and form a dimer, R2. The addition of another protein in the N state to R2 may lead to spontaneous formation of a trimer, R3. These results reveal the molecular basis for a model of prion disease propagation or conformational diseases in general.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. 1. Nymeyer, H., Garcia, A. E. and Onuchic, J. N. (1998) Folding funnels and frustration in off-lattice minimalist protein landscapes. Proc. Natl. Acad. Sci. USA 95, 5921

    CAS  PubMed  Google Scholar 

  2. 2. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136

    CAS  PubMed  Google Scholar 

  3. 3. Prusiner, S. B. (1991) Molecular biology of prion diseases. Science 252, 1515

    CAS  PubMed  Google Scholar 

  4. 4. Aguzzi, A. and Polymenidou, M. (2004) Mammalian prion biology: One century of evolving concepts. Cell 116, 313

    CAS  PubMed  Google Scholar 

  5. 5. Prusiner, S. B., Bolton, D. C., Groth, D. F., Bowman, K. A., Cochran, S. P. and McKinley, M. P. (1982) Further purification and characterization of scrapie prion. Biochemistry 21, 6942

    CAS  PubMed  Google Scholar 

  6. 6. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F. and Glenner, G. G. (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349

    CAS  PubMed  Google Scholar 

  7. 7. Pan, K.-M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., Cohen, F. E. and Prusiner, S. B. (1993) Conversion of alpha-helices beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90, 10962

    CAS  PubMed  Google Scholar 

  8. 8. Safar, J., Roller, P. P., Gajdusek, D. C. and Gibbs, C. J. Jr. (1993) Thermal stability and con-formational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci. 2, 2206

    CAS  PubMed  Google Scholar 

  9. 9. Prusiner, S. B. (1994) Biology and genetics of prion diseases. Annu. Rev. Microbiol. 48, 655

    CAS  PubMed  Google Scholar 

  10. 10. Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T. and Caughey, B. (1994) Cell-free formation of protease-resistant prion protein. Nature 370, 471

    CAS  PubMed  Google Scholar 

  11. 11. Nguyen, J., Baldwin, M. A., Cohen, F. E. and Prusiner, S. B. (1995) Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. Biochemistry 34, 4186

    CAS  PubMed  Google Scholar 

  12. 12. Pergami, P., Jaffe, H. and Safar, J. (1998) Semipreparative chromatographic method to purify the normal cellular isoform of the prion protein in nondenatured form. Anal. Biochem. 236, 63

    Google Scholar 

  13. 13. Harrison, P. M., Bamborough, P., Daggett, V., Prusiner, S. B. and Cohen, F. E. (1997) The prion folding problem. Curr. Opin. Struct. Biol. 7, 53

    CAS  PubMed  Google Scholar 

  14. 14. Horwich, A. L. and Weissman, J. S. (1997) Deadly conformations misfolding in prion disease. Cell 89, 499

    CAS  PubMed  Google Scholar 

  15. 15. Bossers, A., Rigter, A., de Vries, R. and Smits, M. A. (2003) In vitro conversion of normal prion protein into pathologic isoforms. Clin. Lab. Med. 23, 227

    PubMed  Google Scholar 

  16. 16. Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., Prusiner, S. B. and Weissmann, C. (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40, 735

    CAS  PubMed  Google Scholar 

  17. 17. Meyer, R. K., McKinley, M. P., Bowman, K. A., Braunfeld, M. B., Barry, R. A. and Prusiner, S. B. (1986) Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 83, 2310

    CAS  PubMed  Google Scholar 

  18. 18. Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F. and Caughey, W. S. (1991) Secondary structure analysis of the scrapie-associated protein PrP 27–30 in water by infrared spectroscopy. Biochemistry 30, 7672

    CAS  PubMed  Google Scholar 

  19. 19. Kocisko, D. A., Priola, S. A., Raymond, G. J., Chesebro, B., Lansbury, P. T. Jr. and Caughey, B. (1995) Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier. Proc. Natl. Acad. Sci. USA 92, 3923

    CAS  PubMed  Google Scholar 

  20. 20. Borchelt, D. R., Scott, M., Taraboulos, A., Stahl, N. and Prusiner, S. B. (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell Biol. 110, 743

    CAS  PubMed  Google Scholar 

  21. 21. Borchelt, D. R., Taraboulos, A. and Prusiner, S. B. (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267, 16188

    CAS  PubMed  Google Scholar 

  22. 22. Taraboulos, A., Raeber, A. J., Borchelt, D. R., Serban, D. and Prusiner, S. B. (1992) Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3, 851

    CAS  PubMed  Google Scholar 

  23. 23. Caughey, B. and Raymond, G. J. (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266, 18217

    CAS  PubMed  Google Scholar 

  24. 24. DeArmond, S. J., McKinley, M. P., Barry, R. A., Braunfeld, M. B., McColloch, J. R. and Prusiner, S. B. (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41, 221

    CAS  PubMed  Google Scholar 

  25. 25. Kitamoto, T., Tateishi, J., Tashima, T., Takeshita, I., Barry, R. A., DeArmond, S. J. and Prusiner, S. B. (1986) Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann. Neurol. 20, 204

    CAS  PubMed  Google Scholar 

  26. 26. Roberts, G. W., Lofthouse, R., Allsop, D., Landon, M., Kidd, M., Prusiner, S. B. and Crow, T. J. (1988) CNS amyloid proteins in neurodegenerative diseases. Neurology38, 1534

    CAS  PubMed  Google Scholar 

  27. 27. Tagliavini, F., Prelli, F., Ghiso, J., Bugiani, O., Serban, D., Prusiner, S. B., Farlow, M. R., Ghetti, B. and Frangione, B. (1991) Amyloid protein of Gerstmann-Straussler-Scheinker disease (Indiana kindred) is an 11 kD fragment of prion protein with an N-terminal glycine at codon 58. EMBO J. 10, 513

    CAS  PubMed  Google Scholar 

  28. 28. Lynn, D. G. and Meredith, S. C. (2000) Review: Model peptides and the physicochemical approach to beta-amyloids. J. Structur. Biol. 130, 153

    CAS  Google Scholar 

  29. 29. Prusiner, S. B. (2001) Neurodegenerative diseases and prions. N. Engl. J. Med. 344, 1516

    CAS  PubMed  Google Scholar 

  30. 30. Gasset, M., Baldwin, M. A., Lloyd, D. H., Gabriel, J.-M., Holtzman, D. M., Cohen, F., Flet-terick, R. J. and Prusiner, S. B. (1992) Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. USA 89, 10940

    CAS  PubMed  Google Scholar 

  31. 31. Gasset, M., Baldwin, M. A., Fletterick, R. J. and Prusiner, S. B. (1993) Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. USA 90, 1

    CAS  PubMed  Google Scholar 

  32. 32. Huang, Z., Gabriel, J.-M., Baldwin, M. A., Fletterick, R. J., Prusiner, S. B. and Cohen, F. E. (1994) Proposed three-dimensional structure for the cellular prion protein. Proc. Natl. Acad. Sci. USA 91, 7139

    CAS  PubMed  Google Scholar 

  33. 33. Huang, Z., Prusiner, S. B. and Cohen, F. E. (1995) Scrapie prions: a three-dimensional model of an infectious fragment. Fo l d . D e s . 1, 13

    Google Scholar 

  34. 34. Zhang, H., Kaneko, K., Nguyen, J. T., Livshits, T. L., Baldwin, M. A., Cohen, F. E., James, T. L. and Prusiner, S. B. (1995) Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J. Mol. Biol. 250, 514

    CAS  PubMed  Google Scholar 

  35. 35. James, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donnes, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B. and Cohen, F. E. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94, 10086

    CAS  PubMed  Google Scholar 

  36. 36. Liu, H., Farr-Jones, S., Ulyanov, N. B., Llinas, M., Marqusee, S., Groth, D., Cohen, F. E., Prusiner, S. B. and James, T. L. (1999) Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry 38, 5362

    CAS  PubMed  Google Scholar 

  37. 37. Garcia, F. L., Zahn, R., Riek, R. and Wuthrich, K. (2000) NMR structure of the bovine prion protein. Proc. Natl. Acad. Sci. USA 18, 8334

    Google Scholar 

  38. 38. Calzolai, L., Lysek, D. A., Gunter, P., von Schroetter, C., Riek, R., Zahn, R. and Wuthrich, K. (200) NMR structures of three single-residue variants of the human prion protein. Proc. Natl. Acad. Sci. USA 97, 8340

    CAS  PubMed  Google Scholar 

  39. 39. Zahn, R., Liu, A., Luhrs, T., Riek, R., von Schroetter, C., Garcia, F. L., Billeter, M., Calzolai, L., Wider, G. and Wuthrich, K. (2000) NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97, 145

    CAS  PubMed  Google Scholar 

  40. 40. Knaus, K. J., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W. K. and Yee, V. C. (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8, 770

    CAS  PubMed  Google Scholar 

  41. 41. Riek, R. and Luhrs, T. (2003) Three-dimensional structures of the prion protein and its dop-pel. Clin. Lab. Med. 23, 209

    PubMed  Google Scholar 

  42. 42. Gossert, A. D., Bonjour, S., Lysek, D. A., Fiorito, F. and Wuthrich, K. (2005) Prion protein NMR structures of elk and of mouse-elk hybrids. Proc. Natl. Acad. Sci. USA 102, 646

    CAS  PubMed  Google Scholar 

  43. 43. Prusiner, S. B., Groth, D., Serban, A., Koehler, K., Foster, D., Torchia, M., Burton, D., Yang, S.-L. and DeArmond, S. J. (1993) Ablation of the prion (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. USA 90, 10608

    CAS  PubMed  Google Scholar 

  44. 44. Prusiner, S. B., Groth, D., Serban, A., Stahl, N. and Gabizon, R. (1993) Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc. Natl. Acad. Sci. USA 90, 2793

    CAS  PubMed  Google Scholar 

  45. 45. Cohen, F. E., Pan, K.-M., Huang, Z., Baldwin, M. and Fletterick, R. J. (1994) Structural clues to prion replication. Science 264, 530

    CAS  PubMed  Google Scholar 

  46. 46. Benzinger, T. L. S., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E. and Meredith, S. C. (1998) Propagating structure of Alzheimer's beta-amyloid (10–35) is parallel beta-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA 95, 13407

    CAS  PubMed  Google Scholar 

  47. 47. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363

    CAS  PubMed  Google Scholar 

  48. 48. DeArmond, S. J. (2004) Discovering the mechanisms of neurodegeneration in prion diseases. Neurochem. Res. 29, 1979

    CAS  PubMed  Google Scholar 

  49. 49. Safar, J. G., Geschwind, M. D., Deering, C., Didorenko, S., Sattavat, M., Sanchez, H., Serban, A., Vey, M., Baron, H., Giles, K., Miller, B. L., DeArmond, S. J., Prusiner, S. B. (2005) Diagnosis of human prion disease. Proc. Natl. Acad. Sci. USA 102, 3501

    CAS  PubMed  Google Scholar 

  50. 50. Prusiner, S. B. (1996) Molecular biology and pathogenesis of prion diseases. Trends Biochem. Sci. 21, 482

    CAS  PubMed  Google Scholar 

  51. 51. Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastri-anni, J., Lugaresi, E., Gambetti, P. and Prusiner, S. B. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274, 2079

    CAS  PubMed  Google Scholar 

  52. 52. Prusiner, S. B. (1997) Prion diseases and BSE crisis. Science 278, 245

    CAS  PubMed  Google Scholar 

  53. 53. Cashman, N. R. (1997) A prion primer. Can. Med. Assoc. J. 157, 1381

    CAS  Google Scholar 

  54. 54. Riek, R., Wider, G., Billeter, M., Hornemann, S., Glockshuber, R. and Wuthrich, K. (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc. Natl. Acad. Sci. USA 95, 11667

    CAS  PubMed  Google Scholar 

  55. 55. Scott, M. R., Will, R., Ironside, J., Nguyen, H.-O. B., Tremblay, P., DeArmond, S. J. and Prusiner, S. B. (1999) Compelling transgenetic evidence for transmission of bovine spongi-form encephalopathy prions to humans. Proc. Natl. Acad. Sci. USA 96, 15137

    CAS  PubMed  Google Scholar 

  56. 56. Mastrianni, J. A. and Roos, R. P. (2000) The prion diseases. Semin. Neurol. 20, 337

    CAS  PubMed  Google Scholar 

  57. 57. Pedersen, N. S. and Smith, E. (2002) Prion diseases: Epidemiology in man. Acta Pathol. Mic. Sc. 110, 14

    Google Scholar 

  58. 58. Dalsgaard, N. J. (2002) Prion diseases. An overview. Acta Pathol. Mic. Sc. 110, 3

    CAS  Google Scholar 

  59. 59. Jacobsen, J. S. (2002) Alzheimer's disease: An overview of current and emerging therapeutic strategies. Curr. Top. Med. Chem. 2, 343

    CAS  PubMed  Google Scholar 

  60. 60. DeArmond, S. J. and Prusiner, S. B. (2003) Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin. Lab. Med. 23, 1

    PubMed  Google Scholar 

  61. 61. Mastrianni, J. A. (2004) Prion diseases. Clin. Neurosci. Res. 3, 469

    CAS  Google Scholar 

  62. 62. Beghi, E., Gandolfo, C., Ferrarese, C., Rizzuto, N., Poli, G., Tonini, M. C., Vita, G., Leone, M., Logroscino, G., Granieri, E., Salemi, G., Savettieri, G., Frattola, L., Ru, G., Mancardi, G. L. and Messina, C. (2004) Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases. Neurol. Sci. 25, 122

    CAS  PubMed  Google Scholar 

  63. 63. Harder, A., Gregor, A., Wirth, T., Kreuz, F., Schulz-Schaeffer, W. J., Windl, O., Plotkin, M., Amthauer, H., Neukirch, K., Kretzschmar, H. A., Kuhlmann, T., Braas, R., Hahne, H. H. and Jendroska, K. (2004) Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J. Neurol. 251, 715

    CAS  PubMed  Google Scholar 

  64. 64. Olsen, S. B., Sheikh, A., Peck, D. and Darzi, A. (2005) Variant Creutzfeldt-Jakob disease, a cause for concern. Review of the evidence for risk of transmission through abdominal lymphoreticular tissue surgery. Surg. Endosc. 19, 747

    CAS  PubMed  Google Scholar 

  65. 65. Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F. and Caughey, B. (2005) The most infectious prion protein particles. Nature 437, 257

    CAS  PubMed  Google Scholar 

  66. 66. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M. and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339

    CAS  PubMed  Google Scholar 

  67. 67. Race, R. and Chesebro, B. (1998) Scrapie infectivity found in resistant species. Nature 392, 770

    CAS  PubMed  Google Scholar 

  68. 68. Bons, N., Mestre-Frances, N., Belli, P., Cathala, F., Gajdusek, D. C. and Brown, P. (1999) Natural and experimental oral infection of nonhuman primates by bovine spongiform en-cephalopathy agents. Proc. Natl. Acad. Sci. USA 96, 4046

    CAS  PubMed  Google Scholar 

  69. 69. Sweeney, T., Kuczius, T., McElroy, M., Parada, M. G. and Groschup, M. H. (2000) Molecular analysis of Irish sheep scrapie cases. J. Gen. Virol. 81, 1621

    CAS  PubMed  Google Scholar 

  70. 70. Houston, F., Foster, J. D., Chong, A., Hunter, N. and Bostock, C. J. (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356, 999

    CAS  PubMed  Google Scholar 

  71. 71. Crozet, C., Flamant, F., Bencsik, A., Aubert, D., Samarut, J. and Baron, T. (2001) Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene. J. Virol. 75, 5328

    CAS  PubMed  Google Scholar 

  72. 72. Blattler, T. (2002) Transmission of prion disease. Acta Pathol. Mic. Sc. 110, 71

    CAS  Google Scholar 

  73. 73. Hunter, N., Foster, J., Chong, A., McCutcheon, S., Parnham, D., Eaton, S., MacKenzie, C. and Houston, F. (2002) Transmission of prion diseases by blood transfusion. J. Gen. Virol. 83, 2897

    CAS  PubMed  Google Scholar 

  74. 74. Galbraith, D. N. (2002) Transmissible spongiform encephalopathies and tissue cell culture. Cytotechnology 39, 117

    CAS  PubMed  Google Scholar 

  75. 75. Williams, E. S. (2003) Scrapie and chronic wasting disease. Clin. Lab. Med. 23, 139

    PubMed  Google Scholar 

  76. 76. Nonno, R., Esposito, E., Vaccari, G., Conte, M., Marcon, S., Bari, M. D., Ligios, C., Guardo, G. D. and Agrimi, U. (2003) Molecular analysis of cases of Italian sheep scrapie and comparison with cases of bovine spongiform encephalopathy (BSE) and experimental BSE in sheep. J. Clin. Microbiol. 41, 4127

    CAS  PubMed  Google Scholar 

  77. 77. Baron, T., Crozet, C., Biacabe, A.-G., Philippe, S., Verchere, J., Bencsik, A., Madec, J.-Y., Calavas, D. and Samarut, J. (2004) Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wild-type mice. J. Virol. 78, 6243

    CAS  PubMed  Google Scholar 

  78. 78. Browning, S. R., Mason, G. L., Seward, T., Green, M., Eliason, G. A. J., Mathiason, C., Miller, M. W., Williams, E. S., Hoover, E. and Telling, G. C. (2004) Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J. Virol. 78, 13345

    CAS  PubMed  Google Scholar 

  79. 79. Alper, T., Haig, D. A. and Clarke, M. C. (1966) The exceptionally small size of the scrapie agent. Biochem. Bioph. Res. Co. 22, 278

    CAS  Google Scholar 

  80. 80. Latarjet, R., Muel, B., Haig, D. A., Clarke, M. C. and Alper, T. (1985) Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature 227, 1341

    Google Scholar 

  81. 81. DeArmond, S. J., Yang, S.-L., Lee, A., Bowler, R., Taraboulos, A., Groth, D. and Prusiner, S. B. (1993) Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc. Natl. Acad. Sci. USA 90, 6449

    CAS  PubMed  Google Scholar 

  82. 82. Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E. and Prusiner, S. B. (1998) Eight prion strains have PrPSc molecules with different conformations. Nat. Med. 4, 1157

    CAS  PubMed  Google Scholar 

  83. 83. Scott, M. R., Groth, D., Tatzelt, J., Torchia, M., Tremblay, P., DeArmond, S. J. and Prusiner, S. B. (1997) Propagation of prion strains through specific conformers of the prion protein. J. Vi ro l . 71, 9032

    CAS  Google Scholar 

  84. 84. Cohen, F. E. and Prusiner, S. B. (1998) Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793

    CAS  PubMed  Google Scholar 

  85. 85. Bennion, B. J. and Daggett, V. (2000) Protein conformation and diagnostic tests: The prion protein. Clin. Chem. 48, 2105

    Google Scholar 

  86. 86. Kubler, E. and Bruno, O. and Raeber, A. J. (2003) Diagnosis of prion diseases. Brit. Med. Bull. 66, 267

    PubMed  Google Scholar 

  87. 87. Kretzschmar, H. A. (2003) Diagnosis of prion diseases. Clin. Lab. Med.23, 109

    PubMed  Google Scholar 

  88. 88. Aguzzi, A., Heikenwalder, M. and Miele, G. (2004) Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. Clin. Invest. 114, 153

    CAS  Google Scholar 

  89. 89. Wiessmann, C. and Aguzzi, A. (2005) Approaches to therapy of prion diseases. Annu. Rev. Med. 56, 321

    Google Scholar 

  90. 90. Soto, C. (1999) Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches. J. Mol. Med. 77, 412

    CAS  PubMed  Google Scholar 

  91. 91. Soto, C., Kascsak, R. J., Saborio, G. P., Aucouturier, P., Wisniewski, T., Prelli, F., Kascsak, R., Mendez, E., Harris, D. A., Ironside, J., Tagliavini, F., Carp, R. I. and Frangione, B. (2000) Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 355, 192

    CAS  PubMed  Google Scholar 

  92. 92. Rymer, D. L. and Good, T. A. (2000) The role of prion peptide structure and aggregation in toxicity and membrane binding. J. Neurochem. 75, 2536

    CAS  PubMed  Google Scholar 

  93. 93. Korth, C., May, B. C. H., Cohen, F. E. and Prusiner, S. B. (2001) Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 98, 9836

    CAS  PubMed  Google Scholar 

  94. 94. Prusiner, S. B. (1989) Scrapie prions. Annu. Rev. Microbiol. 43, 345

    CAS  PubMed  Google Scholar 

  95. 95. Stahl, N. and Prusiner, S. B. (1991) Prions and prion proteins. FASEB J . 5, 2799

    CAS  PubMed  Google Scholar 

  96. 96. Prusiner, S. B. and DeArmond, S. J. (1994) Prion diseases and neurodegeneration. Annu. Rev. Neurosci. 17, 311

    CAS  PubMed  Google Scholar 

  97. 97. Prusiner, S. B. and Scott, M. R. (1997) Genetics of prions. Annu. Rev. Genet. 31, 139

    CAS  PubMed  Google Scholar 

  98. 98. Prusiner, S. B., Scott, M. R., DeArmond, S. J. and Cohen, F. E. (1998) Prion protein biology. Cell 93, 337

    CAS  PubMed  Google Scholar 

  99. 99. Ziesche, P., Smith, V. H. Jr., Ho, M., Rudin, S. P., Gersdorf, P. and Taut, M. (1999) Theoretical methods and algorithms—the He isoelectronic series and the Hooke's law model: correlation measures and modifications of Collins' conjecture. J. Chem. Phys. 110, 6135

    CAS  Google Scholar 

  100. 100. Harris, D. A. (1999) Cellular biology of prion diseases. Clin. Microbiol. Rev 12, 429

    CAS  PubMed  Google Scholar 

  101. 101. DeArmond, S. J. and Bouzamondo, E. (2002) Fundamentals of prion biology and diseases. Toxicology 181–182, 9

    PubMed  Google Scholar 

  102. 102. Tuite, M. F. and Koloteva-Levin, N. (2004) Propagating prions in fungi and mammals. Mol. Cell 14, 541

    CAS  PubMed  Google Scholar 

  103. 103. Cordeiro, Y., Kraineva, J., Winter, R. and Silva, J. L. (2005) Volume and energy folding landscape of prion revealed by pressure. Braz. J. Med. Biol. Res. 38, 1195

    CAS  PubMed  Google Scholar 

  104. 104. Weissmann, C. (2005) Birth of a prion: Spontaneous generation revisited. Cell 122, 165

    CAS  PubMed  Google Scholar 

  105. 105. Swietnicki, W., Petersen, R., Gambetti, P. and Surewicz, W. K. (1997) pH-dependent stability and conformation of the recombinant human prion protein PrP(90–231). J. Biol. Chem. 272, 27517

    CAS  PubMed  Google Scholar 

  106. 106. Brown, P., Rau, E. H., Bacote, A. E., Gibbs, C. J. and Gajdusek, D. C. (1999) New studies on the heat resistance of hamster-adapted scrapie agent: Threshold survival after ashing at 600 suggests an inorganic template of replication. Proc. Natl. Acad. Sci. USA 97, 3418

    Google Scholar 

  107. 107. Ferreo-Gonzales, A. D., Souto, S. O., Silva, J. L. and Foguel, D. (2000) The preaggregated state of an amyloidogenic protein: Hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc. Natl. Acad. Sci. USA 97, 6445

    Google Scholar 

  108. 108. Torrent, J., Alvarez-Martinez, M. T., Heitz, F., Liautard, J.-P., Balny, C. and Lange, R. (2003) Alternative prion structural changes revealed by high pressure. Biochemistry 42, 1318

    CAS  PubMed  Google Scholar 

  109. 109. Brown, P., Meyer, R., Cardone, F. and Pocchiari, M. (2003) Ultra-high-pressure inactivation of prion infectivity in processed meat: A practical method to prevent human infection. Proc. Natl. Acad. Sci. USA 100, 6093

    CAS  PubMed  Google Scholar 

  110. 110. Martins, S. M., Chapeaurouge, A. and Ferreira, S. T. (2003) Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature. J. Biol. Chem. 278, 50449

    CAS  PubMed  Google Scholar 

  111. 111. Cordeiro, Y., Kraineva, J., Ravindra, R., Lima, L. M. T. R., Gomes, M. P. B., Foguel, D., Winter, R. and Silva, J. L. (2004) Hydration and packing effects on prion folding and beta-sheet conversion: high pressure spectroscopy and pressure perturbation calorimetry studies. J. Biol. Chem. 279, 32354

    CAS  PubMed  Google Scholar 

  112. 112. Silva, J. L., Foguel, D., Suarez, M., Gomes, A. M. O. and Oliveira, A. C. (2004) High-pressure applications in medicine and pharmacology. J. Phys.-Condens. Mat. 16, 0

    Google Scholar 

  113. 113. Garcia, A. F., Heindl, P., Voigt, H., Buttner, M., Butz, P., Tauber, N., Tauscher, B. and Pfaff, E. (2005) Dual nature of the infectious prion protein revealed by high pressure. J. Biol. Chem. 280, 9842

    CAS  PubMed  Google Scholar 

  114. 114. Kazmirski, S. L., Alonso, D. O. V., Cohen, F. E., Prusiner, S. B. and Daggett, V. (1995) Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implications for scrapie formation. Curr. Biol. 2, 305

    CAS  Google Scholar 

  115. 115. Inouye, H., Bond, J., Baldwin, M. A., Ball, H. L., Prusiner, S. B. and Kirschner, D. A. (2000) Structural changes in a hydrophobic domain of the prion protein induced by hydratation and by Ala -> Valand Pro -> Leu substitutions. J. Mol. Biol. 300, 1283

    CAS  PubMed  Google Scholar 

  116. 116. Markossian, K. A. and Kurganov, B. I. (2004) Protein folding, misfolding, and aggregation. Formation of inclusion bodies and aggresomes. Biochemistry (Moscow) 69, 1196

    Google Scholar 

  117. 117. Sigurdsson, B. R. (1954) A chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Brit. Vet. J. 110, 341

    Google Scholar 

  118. The Nobel Assembly at the Karolinska Institute (1997), http://nobelprize.org/nobelprizes/medicine/laureates/1997/press.html.

  119. 119. Kaneko, K., Zulianello, L., Scott, M., Cooper, C. M., Wallace, A. C., James, T. L., Cohen, F. E. and Prusiner, S. B. (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA 94, 10069

    CAS  PubMed  Google Scholar 

  120. 120. Fisher, E., Telling, G. and Collinge, J. (1998) Prions and the prion disorders. Mamm. Genome 9, 497

    CAS  PubMed  Google Scholar 

  121. 121. Soto, C. and Castilla, J. (2004) The controversial protein-only hypothesis of prion propagation. Nat. Med. 10, 0

    CAS  Google Scholar 

  122. 122. Zahn, R. (1999) Prion propagation and molecular chaperones. Q. Rev. Biophys. 4, 309

    Google Scholar 

  123. 123. Jackson, G. S. and Collinge, J. (2000) Prion disease—the propagation of infectious protein topologies. Microbes Infect. 2, 1445

    CAS  PubMed  Google Scholar 

  124. 124. Liebman, S. W. (2002) Progress toward an ultimate proof of the prion hypothesis. Proc. Natl. Acad. Sci. USA 99, 9098

    CAS  PubMed  Google Scholar 

  125. 125. Cohen, F. E. (1999) Protein misfolding and prion diseases. J. Mol. Biol. 293, 313

    CAS  PubMed  Google Scholar 

  126. 126. Jarrett, J. T. and Lansbury, P. T. (1993) Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055

    CAS  PubMed  Google Scholar 

  127. 127. Harper, J. D. and Lansbury, P. T. Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385

    CAS  PubMed  Google Scholar 

  128. 128. Morrissey, M. P. and Shakhnovich, E. I. (1999) Evidence for the role of PrPC helix 1 in the hydrophilic seeding of prion aggregates. Proc. Natl. Acad. Sci. USA 96, 11293

    CAS  PubMed  Google Scholar 

  129. 129. Weissmann, C. (1999) Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem. 274, 3

    CAS  PubMed  Google Scholar 

  130. 130. Hortschansky, P., Schroeckh, V., Christopeit, T., Zandomeneghi, G. and Fandrich, M. (2005) The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14, 1753

    CAS  PubMed  Google Scholar 

  131. 131. Masel, J., Jansen, V. A. A. and Nowak, M. A. (1999) Quantifying the kinetic parameters of prion replication. Biophys. Chem. 77, 139

    CAS  PubMed  Google Scholar 

  132. 132. Poschel, T., Brilliantov, N. V. and Frommel, C. (2003) Kinetics of prion growth. Biophys. J. 85, 3460

    PubMed  Google Scholar 

  133. 133. Slepoy, A., Singh, R. R. P., Pazmandi, F., Kulkarni, R. V. and Cox, D. L. (2001) Statistical mechanics of prion diseases. Phys. Rev. Lett. 87, 58101

    CAS  Google Scholar 

  134. 134. Kulkarni, R. V., Slepoy, A., Singh, R. R. P., Cox, D. L. and Pazmandi, F. (2003) Theoretical modeling of prion disease incubation. Biophys. J. 85, 707

    CAS  PubMed  Google Scholar 

  135. 135. Mobley, D. L., Cox, D. L., Singh, R. R. P., Kulkarni, R. V. and Slepoy, A. (2003) Simulations of oligomeric intermediates in prion diseases. Biophys. J. 85, 2213

    CAS  PubMed  Google Scholar 

  136. Rieger, T. R., Morimoto, R. I. and Hatzimanikatis, V. (2005) Bistability explains threshold phenomena in protein aggregation both in vitro and in vivo. Biophys. J. in press

    Google Scholar 

  137. 137. Zuegg, J. and Gready, J. E. (1999) Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions. Biochemistry 38, 13862

    CAS  PubMed  Google Scholar 

  138. 138. Parchment, O. G. and Essex, J. W. (2000) Molecular dynamics of mouse and Syrian hamster PrP: Implications for activity. Proteins 38, 327

    CAS  PubMed  Google Scholar 

  139. 139. Guilbert, C., Ricard, F. and Smith, J. C. (2000) Dynamic simulation of the mouse prion protein. Biopolymers 54, 406

    CAS  PubMed  Google Scholar 

  140. 140. Zuegg, J. and Gready, J. E. (2000) Molecular dynamics simulation of human prion protein included both N-linked oligosaccharides and the GPI anchor. Glycobiology 10, 959

    CAS  PubMed  Google Scholar 

  141. 141. Okimoto, N., Yamanaka, K., Suenaga, A., Hata, M. and Hoshino, T. (2002) Computational studies on prion proteins: Effect of Ala117->Val mutation. Biophys. J. 82, 2746

    CAS  PubMed  Google Scholar 

  142. 142. Gsponer, J., Haberthur, U. and Caflisch, A. (2003) The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35. Proc. Natl. Acad. Sci. USA 100, 5154

    CAS  PubMed  Google Scholar 

  143. 143. Kuwata, K., Matumoto, T., Cheng, H., Nagayama, K., James, T. L. and Roder, H. (2003) NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106–126. Proc. Natl. Acad. Sci. USA 100, 14790

    CAS  PubMed  Google Scholar 

  144. 144. DeMarco, M. L. and Daggett, V. (2004) From conversion to aggregation: Protofibril formation of the prion protein. Proc. Natl. Acad. Sci. USA 101, 2293

    CAS  PubMed  Google Scholar 

  145. 145. Ma, B. and Nussinov, R. (2004) Molecular dynamics simulations of alanine rich beta-sheet oligomers: Insight into amyloid formation. Protein Sci. 11, 2335

    Google Scholar 

  146. 146. Langella, E., Improta, R. and Barone, V. (2004) Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: Effect of protonation of his-tidine residues. Biophys. J. 87, 3623

    CAS  PubMed  Google Scholar 

  147. 147. Barducci, A., Chelli, R., Procacci, P. and Schettino, V. (2005) Misfolding pathways of the prion protein probed by molecular dynamics simulations. Biophys. J. 88, 1334

    CAS  PubMed  Google Scholar 

  148. 148. Armen, R. S., DeMarco, M. L., Alonso, D. O. V. and Daggett, V. (2004) Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc. Natl. Acad. Sci. USA 101, 11622

    CAS  PubMed  Google Scholar 

  149. 149. Stork, M., Giese, A., Kretzschmar, H. A. and Tavan, P. (2005) Molecular dynamics simulations indicate a possible role of parallel beta-helices in seeded aggregation of poly-Gln. Biophys. J. 88, 2442

    CAS  PubMed  Google Scholar 

  150. 150. Tsai, H.-H., Reches, M., Tsai, C.-J., Gunasekaran, K., Gazit, E. and Nussinov, R. (2005) Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: Significant role of Asn ladder. Proc. Natl. Acad. Sci. USA 102, 8174

    CAS  PubMed  Google Scholar 

  151. 151. Harrison, P. M., Chan, H. S., Prusiner, S. B. and Cohen, F. E. (2001) Conformational propagation with prion-like characteristics in a simple model of protein folding. Protein Sci. 10, 819

    CAS  PubMed  Google Scholar 

  152. 152. Derreumaux, P. (2001) Evidence that the 127–164 region of prion proteins has two equienergetic conformations with beta or alpha features. Biophys. J. 81, 1657

    CAS  PubMed  Google Scholar 

  153. 153. Peng, Y. and Hansmann, U. H. E. (2003) Helix versus sheet formation in a small peptide. Phys. Rev. E 68, 41911

    Google Scholar 

  154. 154. Dimeo, R. M., Neumann, D. A., Glanville, Y. and Minor, D. B. (2002) Pore-size dependence of rotational tunneling in confined methyl iodide. Phys. Rev. B 66, 104201

    Google Scholar 

  155. 155. Kammerer, R. A., Kostrewa, D., Zurdo, J., Detken, A., Garcia-Echeverría, C., Green, J. D., Muller, S. A., Meier, B. H., Winkler, F. K., Dobson, C. M. and Steinmetz, M. O. (2004) Exploring amyloid formation by a de novo design. Proc. Natl. Acad. Sci. USA 101, 4435

    CAS  PubMed  Google Scholar 

  156. 156. Ding, F., LaRocque, J. J. and Dokholyan, N. V. (2005) Direct observation of protein folding, aggregation, and a prion-like conformational conversion. J. Biol. Chem. 280, 40235

    CAS  PubMed  Google Scholar 

  157. 157. Dima, R. I. and Thirumalai, D. (2002) Exploring protein aggregation and self-propagation using lattice models: Phase diagram and kinetics. Protein Sci. 11, 1036

    CAS  PubMed  Google Scholar 

  158. 158. Malolepsza, E., Boniecki, M., Kolinski, A. and Piela, L. (2005) Theoretical model of prion propagation: A misfolded protein induces misfolding. Proc. Natl. Acad. Sci. USA 102, 7835

    CAS  PubMed  Google Scholar 

  159. 159. Lysek, D. A., Nivon, L. G. and Wuthrich, K. (2004) Amino acid sequence of the Felis catusprion protein. Gene 341, 249

    CAS  PubMed  Google Scholar 

  160. 160. Skolnick, J., Zhang, Y., Arakaki, A. K., Kolinski, A., Boniecki, M., Szilagyi, A. and Kihara, D. (2003) A unified approach to protein structure prediction. Proteins 53 (Suppl. 6), 469

    CAS  PubMed  Google Scholar 

  161. 161. Boniecki, M., Rotkiewicz, P., Skolnick, J. and Kolinski, A. (2003) Protein fragment reconstruction using various modeling techniques. Curr. Comp.-Aided Drug Design 17, 725

    CAS  Google Scholar 

  162. 162. Leach, A. R. (1999) Molecular modelling. Principles and applications.Pearson Education Limited, Edinburgh Gate

    Google Scholar 

  163. 163. Metropolis, N., Resenbluth, A. W., Rosenbluth, M. L., Teller, A. H. and Teller, E. (1953) Equation of state calculations by fast computing machines. J. Chem. Phys. 21, 1087

    CAS  Google Scholar 

  164. 164. Kolinski, A. (2004) Protein modeling and structure prediction with a reduced representation. Acta Biochim. Pol. 51, 349

    CAS  PubMed  Google Scholar 

  165. 165. Kolins ki, A. and Skolnick, J. (2004) Reduced models of proteins and their applications. Polymer 45, 511

    CAS  Google Scholar 

  166. Critical assessment of techniques for protein structure prediction (2004) http://prediction-center.org/casp6/Casp6.html.

  167. 167. Tompa, P., Tusnady, G. E., Friedrich, P. and Simon, I. (2002) The role of dimerization in prion replication. Biophys. J. 82, 1711

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Warsaw University, Warsaw, Poland

    Edyta B. Maɫolepsza (Faculty)

Authors
  1. Edyta B. Maɫolepsza
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Andreas Kukol

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Maɫolepsza, E.B. (2008). Modeling of Protein Misfolding in Disease. In: Kukol, A. (eds) Molecular Modeling of Proteins. Methods Molecular Biology™, vol 443. Humana Press. https://doi.org/10.1007/978-1-59745-177-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-177-2_16

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-864-5

  • Online ISBN: 978-1-59745-177-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation